| Literature DB >> 27821766 |
Angel Diaz-Lagares1, Ana B Crujeiras1,2,3, Paula Lopez-Serra1, Marta Soler1, Fernando Setien1, Ashish Goyal4,5, Juan Sandoval1, Yutaka Hashimoto1, Anna Martinez-Cardús1, Antonio Gomez1, Holger Heyn1, Catia Moutinho1, Jesús Espada6,7, August Vidal8, Maria Paúles8, Maica Galán9, Núria Sala10, Yoshimitsu Akiyama11, María Martínez-Iniesta12, Lourdes Farré12,13, Alberto Villanueva12, Matthias Gross4,5, Sven Diederichs4,5,14,15,16, Sonia Guil17, Manel Esteller17,18,19.
Abstract
Long noncoding RNAs (lncRNAs) are important regulators of cellular homeostasis. However, their contribution to the cancer phenotype still needs to be established. Herein, we have identified a p53-induced lncRNA, TP53TG1, that undergoes cancer-specific promoter hypermethylation-associated silencing. In vitro and in vivo assays identify a tumor-suppressor activity for TP53TG1 and a role in the p53 response to DNA damage. Importantly, we show that TP53TG1 binds to the multifaceted DNA/RNA binding protein YBX1 to prevent its nuclear localization and thus the YBX1-mediated activation of oncogenes. TP53TG1 epigenetic inactivation in cancer cells releases the transcriptional repression of YBX1-targeted growth-promoting genes and creates a chemoresistant tumor. TP53TG1 hypermethylation in primary tumors is shown to be associated with poor outcome. The epigenetic loss of TP53TG1 therefore represents an altered event in an lncRNA that is linked to classical tumoral pathways, such as p53 signaling, but is also connected to regulatory networks of the cancer cell.Entities:
Keywords: DNA methylation; cancer; epigenetics; long noncoding RNA
Mesh:
Substances:
Year: 2016 PMID: 27821766 PMCID: PMC5127373 DOI: 10.1073/pnas.1608585113
Source DB: PubMed Journal: Proc Natl Acad Sci U S A ISSN: 0027-8424 Impact factor: 11.205